FDA cell and gene therapy director exit increases ‘volatility’ for sector
Nicole Verdun, a highly respected individual in the cell and gene therapy space, was placed on administrative leave this week.
20 June 2025
Nicole Verdun, a highly respected individual in the cell and gene therapy space, was placed on administrative leave this week.
CEO Dr Katie King said that the microgravity environment enables the production of purer crystals, resulting in more concentrated therapies.
While the UK’s Vaccine Innovation Pathway succeeds, the vaccine future in the US is destabilising.
The financing round was jointly led by new investor Regeneron Ventures and current investor Deerfield Management.
The additional fund is crucial in providing treatment for those who might otherwise have no viable options.
MELAS patients often endure severe symptoms such as chronic fatigue, muscle weakness and cognitive issues.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.